IPOs from digital health companies were at a near two-year standstill until healthcare payments company Waystar and precision medicine company Tempus went public in June. The lack of IPO activity and public skepticism over the efficacy of some digital health tools has led many companies to take a conservative approach to their funding alternatives. Still, there is a growing consensus among investors and industry experts that companies’ need for capital and a slightly improved macroeconomic outlook could produce more IPOs in 2025. Formulating a compelling communications strategy — and doing it early in the process — to put in front of potential investors is said to be key.
Read the full article: Why Digital Health IPO Candidates Need a Better Message //
Source: https://www.modernhealthcare.com/digital-health/ipos-investors-waystar-tempus-livongo